The study, which followed patients for over five years, found that those ⁠who received ⁠the regimen were nine times more likely to have lit...

Pfizer is prioritizing India for future growth. The company plans to launch new medicines here soon after their global release. Pfizer aims...

A hantavirus outbreak on a cruise ship has sparked public concern. Health officials are working to communicate clearly, drawing lessons fro...

Eli Lilly is making Alzheimer's a major focus for its future innovations. The company is also expanding its specialty medicine offerings in...

Prices for generic semaglutide, a popular weight-loss drug, are expected to fall by more than half in the coming months. This sharp decline...

India’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...

Pfizer reported higher-than-expected sales and profit on Tuesday and said a patent extension for its Vyndamax heart drug and a recent favor...

US stock market surges today: why Dow Jones, S&P 500, and Nasdaq are rallying sharply despite global tensions? The Dow Jones Industrial Ave...

Amazon Web Services anticipates several months to restore cloud operations in Bahrain and the UAE following Iranian drone strikes in early ...

US stock market today: Nasdaq crashing big today as Dow Jones and S&P 500 also slip. The US stock market today shows a sharp shift. The Nas...

US company’s board meeting is happening this weekend to finalise decision; an announcement is imminent later tonight or by Monday. Mumbai H...

Indian equities saw a broad-based selloff on Friday, led by IT stocks, dragging benchmarks sharply lower. Nifty fell 1.14% and Sensex dropp...

Kailera Therapeutics shares surged 62.5% in their Nasdaq debut after raising $625 million in a U.S. IPO priced at the top end of its range....

Sun Pharmaceutical Industries is nearing a $12 billion acquisition of Organon & Co, marking its most significant overseas expansion. Follow...

America is set to impose hefty 100% tariffs on imported medicines. This move targets drug companies that do not agree to government pricing...

The Trump administration is reportedly preparing to impose 100% tariffs on drugmakers that haven't secured deals for lower U.S. prices. Sev...

Marksans Pharma has received final approval from the US Food and Drug Administration for its generic version of Benzonatate capsules used t...